A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Clinical trial NCT03319667 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03319667
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-07
- Primary completion
- 2027-04-05
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.